Wei Sha Selected Research

Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2

1/2022	Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
12/2021	Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD.
1/2019	Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
1/2018	Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone.
1/2017	Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth.
1/2014	Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Sha Research Topics

Disease

24	Tuberculosis (Tuberculoses) 08/2022 - 10/2010
23	Neoplasms (Cancer) 02/2022 - 11/2003
17	Inflammation (Inflammations) 02/2022 - 12/2003
10	Infections 12/2022 - 01/2016
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2018
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2022 - 01/2013
3	Chronic Disease (Chronic Diseases) 01/2022 - 04/2011
3	Overweight 07/2020 - 06/2011
3	Lung Diseases (Lung Disease) 01/2020 - 04/2011
3	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 05/2014
3	Breast Neoplasms (Breast Cancer) 11/2018 - 09/2004
2	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 01/2022
2	Mood Disorders (Mood Disorder) 12/2021 - 01/2020
2	Hypoxia (Hypoxemia) 10/2021 - 03/2018
2	Carcinogenesis 08/2021 - 10/2013
2	Pulmonary Tuberculosis 06/2021 - 02/2020
2	Colitis 01/2021 - 10/2013
2	Body Weight (Weight, Body) 01/2021 - 11/2015
2	Obesity 07/2020 - 05/2016
2	Mental Disorders (Mental Disorder) 01/2020 - 01/2013
2	Chemical and Drug Induced Liver Injury 01/2020 - 01/2016
2	Lung Injury 01/2019 - 01/2018
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2018 - 01/2018
2	Fever (Fevers) 07/2016 - 12/2011
2	Wounds and Injuries (Trauma) 01/2016 - 04/2012
2	Hypersensitivity (Allergy) 06/2015 - 04/2011
2	Myocardial Infarction 03/2015 - 02/2014
1	Colitis-Associated Neoplasms 02/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2021
1	Granuloma 10/2021
1	Pituitary Neoplasms (Pituitary Adenoma) 08/2021
1	Lymph Node Tuberculosis (Scrofula) 04/2021
1	Lymphadenitis (Adenitis) 04/2021
1	Sarcoidosis (Schaumann Disease) 01/2021

Drug/Important Bio-Agent (IBA)

13	Pharmaceutical PreparationsIBA 01/2021 - 11/2003
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
9	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 02/2022 - 01/2014
8	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2003
7	Rifampin (Rifampicin)FDA LinkGeneric 08/2022 - 10/2010
6	Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA 01/2022 - 01/2014
5	somatotropin releasing hormone receptorIBA 12/2021 - 03/2015
5	N-Me-Tyr1,D-Ala2,Asn8,Arg29-NHCH3-JI-38IBA 01/2021 - 02/2014
4	MIA-690IBA 02/2022 - 01/2019
4	Isoniazid (Ftivazide)FDA LinkGeneric 04/2021 - 04/2011
4	Peptides (Polypeptides)IBA 01/2021 - 01/2011
4	AntigensIBA 01/2020 - 01/2016
4	EnzymesIBA 01/2020 - 01/2011
3	CytokinesIBA 10/2021 - 11/2013
3	Interferon-gamma (Interferon, gamma)IBA 06/2021 - 01/2016
3	Hormones (Hormone)IBA 01/2021 - 01/2017
3	AntioxidantsIBA 01/2020 - 06/2011
2	Interleukin-2 (IL2)IBA 12/2022 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 06/2010
2	Long Noncoding RNAIBA 01/2022 - 12/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2021 - 09/2019
2	ProstaglandinsIBA 01/2021 - 07/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2014
2	InterleukinsIBA 01/2021 - 03/2014
2	Biological ProductsIBA 12/2020 - 11/2016
2	CarbohydratesIBA 07/2020 - 01/2012
2	KynurenineIBA 01/2020 - 09/2019
2	GoldIBA 01/2020 - 12/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2015
2	Tryptophan (L-Tryptophan)FDA Link 01/2020 - 09/2019
2	C-Reactive ProteinIBA 01/2019 - 11/2013
2	CyclinsIBA 11/2018 - 01/2018
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2018 - 04/2012
2	salvianolic acid BIBA 11/2018 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 03/2018 - 01/2005
2	Lipoproteins (Lipoprotein)IBA 01/2018 - 01/2018
2	VaccinesIBA 01/2018 - 01/2016
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2016 - 06/2011
2	FlavonoidsIBA 05/2016 - 04/2013
2	QuercetinIBA 05/2016 - 06/2011
2	Therapeutic UsesIBA 11/2015 - 04/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 02/2012
2	Choline (Choline Chloride)IBA 04/2013 - 08/2010
2	Blood Glucose (Blood Sugar)IBA 01/2013 - 01/2012
2	Immunoglobulin G (IgG)IBA 04/2011 - 01/2011
2	OligodeoxyribonucleotidesIBA 01/2005 - 11/2003
1	Zoledronic Acid (Zometa)FDA Link 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	sotorasibIBA 01/2022
1	adagrasibIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 10/2021
1	Acetates (Acetic Acid Esters)FDA Link 10/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	arabinogalactanIBA 01/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Dextrans (Dextran)FDA Link 01/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 11/2003
3	Drug Therapy (Chemotherapy) 04/2021 - 02/2012
2	Punctures 04/2021 - 11/2020
2	Retreatment 01/2021 - 12/2011
1	Immunotherapy 12/2022